These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1354616)
1. Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris. Riley M; Elborn JS; Khan MM; Stanford CF; Nicholls DP Eur Heart J; 1992 Aug; 13(8):1116-22. PubMed ID: 1354616 [TBL] [Abstract][Full Text] [Related]
2. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris. Vandenbosch H; Piessens J; De Geest H Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394 [TBL] [Abstract][Full Text] [Related]
3. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris. Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150 [TBL] [Abstract][Full Text] [Related]
4. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group. Boberg J; Larsen FF; Pehrsson SK Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086 [TBL] [Abstract][Full Text] [Related]
5. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy. Akhras F; Jackson G Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance. Rydén L J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268 [TBL] [Abstract][Full Text] [Related]
7. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial. Blake P; Berry SC; Readman A; Ratcliffe M; Godley M Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942 [TBL] [Abstract][Full Text] [Related]
8. Dose finding in angina--results with epanolol. Omland TM; von Brandis C; Abrahamsen AM Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978 [No Abstract] [Full Text] [Related]
9. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris. Readman AS Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983 [TBL] [Abstract][Full Text] [Related]
10. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina. Chambers J; Ong ML; Akhras F; Adam G; Jackson G Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979 [TBL] [Abstract][Full Text] [Related]
11. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris. Clark-Turner N Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris]. de Caprio L; Sestito M; Pandolfi E; Santamaria F; di Palma A; Lombardi L; Voza A; De Rosa ML; Cicatiello AM; Rengo F G Ital Cardiol; 1994 Feb; 24(2):115-22. PubMed ID: 8013763 [TBL] [Abstract][Full Text] [Related]
13. Short- and long-term efficacy of high-dose oral diltiazem for angina due to coronary artery disease: a placebo-controlled, randomized, double-blind crossover study. Petru MA; Crawford MH; Sorensen SG; Chaudhuri TK; Levine S; O'Rourke RA Circulation; 1983 Jul; 68(1):139-47. PubMed ID: 6851041 [TBL] [Abstract][Full Text] [Related]
14. A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris. Erikssen J; Rollag A; Otterstad JE Acta Med Scand; 1988; 223(1):35-43. PubMed ID: 2894747 [TBL] [Abstract][Full Text] [Related]
15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris. Glasser SP; Gana TJ; Pascual LG; Albert KS Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251 [TBL] [Abstract][Full Text] [Related]
18. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN). van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820 [TBL] [Abstract][Full Text] [Related]
19. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622 [TBL] [Abstract][Full Text] [Related]
20. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group. Heller GV; Sridharan M; Morse J; Glasser S; Beach CL Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]